Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 23, 2017

DrugPatentWatch Database Preview

Atazanavir sulfate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for atazanavir sulfate and what is the scope of atazanavir sulfate freedom to operate?

Atazanavir sulfate
is the generic ingredient in three branded drugs marketed by Bristol Myers Squibb, Teva Pharms Usa, and Bristol-myers Squibb, and is included in four NDAs. There are four patents protecting this compound and three Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Atazanavir sulfate has ninety-three patent family members in forty-two countries.

There are twenty-three drug master file entries for atazanavir sulfate. Seven suppliers are listed for this compound. There are seven tentative approvals for this compound.

Summary for Generic Name: atazanavir sulfate

Drug Master File Entries: see list23
Suppliers / Packagers: see list7
Bulk Api Vendors: see list36
Clinical Trials: see list364
Patent Applications: see list34
Therapeutic Class:Antivirals
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:atazanavir sulfate at DailyMed

Tentative approvals for ATAZANAVIR SULFATE

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe300MG/100MGTABLET; ORAL
► Subscribe► Subscribe100MGCAPSULE; ORAL
► Subscribe► Subscribe200MGCAPSULE; ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb
atazanavir sulfate
CAPSULE;ORAL021567-003Jun 20, 2003ABRXYesNo5,849,911*PED► SubscribeY► Subscribe
Bristol Myers Squibb
atazanavir sulfate
POWDER;ORAL206352-001Jun 2, 2014RXYesYes► Subscribe► Subscribe
Bristol-myers Squibb
atazanavir sulfate; cobicistat
TABLET;ORAL206353-001Jan 29, 2015RXYesYes8,148,374► SubscribeYY ► Subscribe
Bristol Myers Squibb
atazanavir sulfate
CAPSULE;ORAL021567-004Oct 16, 2006ABRXYesYes6,087,383*PED► SubscribeY► Subscribe
Bristol Myers Squibb
atazanavir sulfate
CAPSULE;ORAL021567-001Jun 20, 2003DISCNYesNo6,087,383*PED► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Find generic sources and suppliers
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus